PDGFRB and systemic sclerosis: In SCID mice, transferred SSc patient IgG or agonistic anti-PDGFR antibodies induced increased collagen deposition and fibroblast activation from the 3D bioengineered skin grafts that contained human keratinocytes and fibroblasts from healthy donor skins [100].